Contract 75N95C22F00001
Lonza Walkersville, Inc · Department Of Health And Human Services · November 18, 2021
Lonza Walkersville, Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on November 18, 2021 for $59,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Walkersville, MD. This is a task or delivery order issued under parent IDIQ HHSN263201600052B. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 12, 2022.
Contract details
- PIID
- 75N95C22F00001
- Parent IDIQ
- HHSN263201600052B
- Award type
- Bpa Call
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Walkersville, MD
- First action
- November 18, 2021
- Latest action
- September 12, 2022
Description
NOSPIN HEPARG (8.0M CELLS / VIAL)
Modification timeline
-
September 12, 2022Base award$24.9K
-
May 21, 2022Base awardMEA VIABILITY MODULE FOR MAESTRO PRO$11.0K
-
November 18, 2021Base awardPERFORM CONFLICT OF INTEREST CHECK. REFERENCE NO.: E-234-2020-0-PCT-02,$22.7K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N95C22F00001?
Contract 75N95C22F00001 is a federal contract awarded to Lonza Walkersville, Inc by Department Of Health And Human Services on November 18, 2021 for $59,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 75N95C22F00001?
Lonza Walkersville, Inc won contract 75N95C22F00001 from Department Of Health And Human Services.
How much is contract 75N95C22F00001 worth?
Contract 75N95C22F00001 has obligated $59,000 to date.